FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 173 filers reported holding FIBROGEN INC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $227,799 | -96.2% | 84,370 | -73.9% | 0.00% | -96.7% |
| Q1 2023 | $6,043,209 | +189.6% | 323,859 | +101.9% | 0.03% | +172.7% |
| Q3 2022 | $2,087,000 | -47.1% | 160,401 | -57.1% | 0.01% | -45.0% |
| Q2 2022 | $3,945,000 | -10.1% | 373,618 | +2.3% | 0.02% | -20.0% |
| Q1 2022 | $4,389,000 | -19.0% | 365,167 | -4.9% | 0.02% | -16.7% |
| Q4 2021 | $5,416,000 | -35.6% | 384,131 | -53.3% | 0.03% | -44.4% |
| Q3 2021 | $8,404,000 | +25.0% | 822,331 | +225.8% | 0.05% | +14.9% |
| Q2 2021 | $6,721,000 | +438.1% | 252,392 | +718.9% | 0.05% | +235.7% |
| Q2 2020 | $1,249,000 | +109.6% | 30,819 | +121.8% | 0.01% | +16.7% |
| Q4 2019 | $596,000 | -13.6% | 13,895 | -4.6% | 0.01% | -20.0% |
| Q4 2017 | $690,000 | -81.0% | 14,559 | -78.4% | 0.02% | -81.5% |
| Q3 2017 | $3,625,000 | – | 67,384 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
| ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
| BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
| Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
| Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
| Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
| PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
| Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |